Stay updated with breaking news from Statistically Significant Reductions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and DysfunctionPRINCETON, N.J., Jan. 17, 2024 -- CytoSorbents Corporation , a leader in the...
17.01.2024 - CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and DysfunctionPRINCETON, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) - CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of ... Seite 1
Blueprint Medicines Data Highlight Clinical Leadership in Systemic Mastocytosis at AACR Annual Meeting 2021 -- 75% confirmed ORR, with all responses ongoing, in PATHFINDER trial of AYVAKIT in advanced SM -- -- New patient-reported outcomes data from PATHFINDER trial show AYVAKIT significantly reduced disease symptoms and improved quality of life -- -- BLU-263 was well-tolerated across all doses tested in Phase 1 healthy volunteer trial, supporting plans to initiate Phase 2/3 HARBOR trial in non-advanced SM in mid-2021 -- -- Blueprint Medicines to host investor conference call and webcast on M...